Work

A phase I trial of pomalidomide in combination with liposomal doxorubicin in the treatment of advanced or refractory Kaposi sarcoma in individuals with or without HIV.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps11586

Authors: Ramya Ramaswami, Kathryn Anne Lurain, Priscila Hermont Goncalves, Anaida Widell, Matthew Lindsley, William Douglas Figg, Cody J. Peer, Seth M. Steinberg, Vikram Khetani, Peter L. Choyke, Joseph R Fontana, Denise Whitby, Thomas S. Uldrick, Robert Yarchoan

Institutions: National Cancer Institute, Center for Cancer Research, National Institutes of Health, Celgene (United States), National Heart, Lung, and Blood Institute, Frederick National Laboratory for Cancer Research

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891080223

Cites:

Cited by: 2

Related to: 10